Literature DB >> 15519641

Isoflurane pretreatment lowers portal venous resistance by increasing hepatic heme oxygenase activity in the rat liver in vivo.

Rene Schmidt1, Alexander Hoetzel, Tilo Baechle, Torsten Loop, Matjaz Humar, Michael Bauer, Heike L Pahl, Klaus K Geiger, Benedikt H J Pannen.   

Abstract

BACKGROUND/AIMS: The heme oxygenase (HO) system contributes to the maintenance of hepatic perfusion and integrity. It was the objective of this study to determine the influence of isoflurane (ISO) on hepatic HO-1 induction and its impact on hepatic hemodynamics.
METHODS: Rats were pretreated with or without ISO for 5h. After hemodynamic measurements by pressure-, laser doppler-, and ultrasound based techniques, the liver was harvested. HO-1 was analyzed by an HO activity assay, Northern- and Western blotting.
RESULTS: ISO pretreatment induced hepatic HO-1 mRNA and protein resulting in an increase of HO activity. No effect on hsp-27, hsp-70 and hsp-90 mRNA could be observed. ISO lowered portal resistance. HO inhibition by tin protoporphyrine IX increased portal resistance in ISO pretreated animals up to control levels. This was associated with an increase in portal pressure and a reduction of portal flow. Microvascular flux was also impaired after HO blockade and ISO. However, hepatic arterial and systemic hemodynamics remained unchanged, indicating a specific effect within the portal vascular bed.
CONCLUSIONS: ISO pretreatment induces hepatic HO-1 mRNA and protein followed by an increase in HO activity, thereby reducing portal resistance. These findings indicate a beneficial effect of ISO on hepatic hemodynamics in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519641     DOI: 10.1016/j.jhep.2004.07.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Hepatic steatosis prevents heme oxygenase-1 induction by isoflurane in the rat liver.

Authors:  Patrick Stoll; Christian I Schwer; Ulrich Goebel; Hartmut Buerkle; Alexander Hoetzel; Rene Schmidt
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 2.  [Carbon monoxide--poison or potential therapeutic?].

Authors:  A Hoetzel; R Schmidt
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

3.  Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury.

Authors:  Rene Schmidt; Eva Tritschler; Alexander Hoetzel; Torsten Loop; Matjaz Humar; Leonie Halverscheid; Klaus K Geiger; Benedikt H J Pannen
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

4.  Isoflurane preconditioning at clinically relevant doses induce protective effects of heme oxygenase-1 on hepatic ischemia reperfusion in rats.

Authors:  Xin Lv; Liqun Yang; Kunming Tao; Yantao Liu; Tian Yang; Guozhong Chen; Weifeng Yu; Hao Lv; Feixiang Wu
Journal:  BMC Gastroenterol       Date:  2011-03-31       Impact factor: 3.067

5.  Cobalt protoporphyrin accelerates TFEB activation and lysosome reformation during LPS-induced septic insults in the rat heart.

Authors:  Kana Unuma; Toshihiko Aki; Takeshi Funakoshi; Ken-ichi Yoshida; Koichi Uemura
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

6.  The Cytoprotective Effects of E-α-(4-Methoxyphenyl)-2',3,4,4'-Tetramethoxychalcone (E-α-p-OMe-C6H4-TMC)--A Novel and Non-Cytotoxic HO-1 Inducer.

Authors:  Kai B Kaufmann; Nafisah Al-Rifai; Felix Ulbrich; Nils Schallner; Hannelore Rücker; Monika Enzinger; Hermina Petkes; Sebastian Pitzl; Ulrich Goebel; Sabine Amslinger
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

Review 7.  The Role of Heme Oxygenase-1 in Remote Ischemic and Anesthetic Organ Conditioning.

Authors:  Inge Bauer; Annika Raupach
Journal:  Antioxidants (Basel)       Date:  2019-09-16

8.  Short-term inhalation of isoflurane improves the outcomes of intraportal hepatocyte transplantation.

Authors:  Hiroyasu Nishimaki; Yoshikatsu Saitoh; Akiko Inagaki; Yasuhiro Nakamura; Takehiro Imura; Ibrahim Fathi; Hiroki Yamana; Kazuo Ohashi; Shigehito Miyagi; Takashi Kamei; Michiaki Unno; Masafumi Goto
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.